NeoProteomics Inc is trying to accelerate the process of drug and diagnostics development by providing innovative informatics solutions allowing clients to achieve biological understanding of their genomics and proteomics data at the systems level. NeoProteomics has licensed an attractive IP portfolio from Case Western Reserve University (CWRU), which serves as the foundation of cutting edge services that help researchers increase the speed and accuracy of their biologics and small molecular drug development. NeoProteomics' solutions to customer problems provide fast and intuitive data analysis for assessing the structures of biologics and a navigable road map of the cell for understanding pharmaceutical drug targets, drug efficacy, and drug safety.
